TY - CHAP M1 - Book, Section TI - Chapter 63. Axillary Lymph Node Dissection A1 - Neuman, Heather B. A1 - Van Zee, Kimberly J. A2 - Kuerer, Henry M. PY - 2010 T2 - Kuerer's Breast Surgical Oncology AB - The status of the axillary lymph nodes is the most significant factor predictive of long-term survival in patients with breast cancer. Axillary lymph node dissection (ALND) is an effective staging procedure and provides durable local control with a low rate of recurrence (NSABP B-4).1 Furthermore, although ALND has never been associated with an improvement in overall survival in individual randomized controlled trials (RCT), a meta-analysis of trials comparing ALND with observation suggests that a benefit exists.2 SN - PB - The McGraw-Hill Companies CY - New York, NY Y2 - 2024/10/10 UR - accesssurgery.mhmedical.com/content.aspx?aid=6414647 ER -